| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 724794 | 5-Benzyl-9-hydroxy-5H-indeno[1,2-b]indol-10-one | 0.0420893367628879 | -0.060670013 |
| NSC 724827 | 1,4-di-N-oxide-6,7-difluoro-2-ethylcarbonyl-3-trifluoromethy lquinoxaline | 0.0420893367628879 | 0.058706112 |
| NSC 726863 | 6-[4-(1-cyclohexenyl)-1,3-butadiyn-1-yl]-2(2H)-pyranone | 0.0420893367628879 | 0.037045589 |
| NSC 727985 | NSC 708781 incorporated in micelles, 0.55% (w/w) of drug | 0.0420893367628879 | 0.51926671 |
| NSC 728319 | 6-(3-Homopiperazinyl1-1-propyl)-5,6-dihydro-2,3-dimethoxy-8, 9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Dihydrochloride | 0.0420893367628879 | 0.33174662 |
| NSC 731155 | 6-(3-Aminopropyl)-5,6-dihydro-5,11-dioxo-3-nitro-11H-indeno[ 1,2-c]isoquinoline Hydrochloride salt | 0.0420893367628879 | 0.20549014 |
| NSC 737318 | 6-(3-Chloropropyl)-5,6-dihydro-2,3,9-trimethoxy-5,11-dioxo-1 1H-indeno[1,2-c]isoquinoline | 0.0420893367628879 | 0.26628833 |
| NSC 740386 | 3,7-di(trifluoromethyl)-2-furoylquioxaline 1,4-dioxide | 0.0420893367628879 | 0.35542247 |
| NSC 254681 | 5(8H)-Naphthacenone, 8-acetyl-10-[(3-amino-2,3,6-trideoxy- .alpha.-L-lyxo-hexopyranosyl)oxy]-7,9,10,12-tetrahydro-6,8,~ 11-trihydroxy-12-imino-1-methoxy-, monohydrochloride, (8S-cis)- (9CI) | 0.0430277102950697 | 0.23690522 |
| NSC 269599 | Stannane, chlorohydroxydiphenyl- | 0.0430277102950697 | 0.045987267 |